News

May 8, 2017 | TCTMD

“A new survey quantifying the salaries of American physicians sheds light on some jaw-dropping regional differences and disparities between men and women.”

May 8, 2017 | Industry Press Releases

“Abbott today announced that the French Health Ministry has granted national reimbursement across France for FreeStyle® Libre—Abbott’s revolutionary glucose monitoring technology that removes the need for routine finger sticks1 for people with diabetes. This reimbursement decision will mean access to the FreeStyle Libre system for hundreds of thousands of people from age four3 across France […]

May 8, 2017 | Industry Press Releases

“Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm Rx™ Insertable Cardiac Monitor (ICM), the world’s first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy. Since CE Mark approval, adoption of the device has been strong and […]

May 5, 2017 | TCTMD

“Although there is no randomized trial evidence showing that PCI for patients with chronic total occlusion (CTO) lesions improves hard outcomes or even quality of life, another observational study shows that the procedure can be successfully performed in a large group of veterans with obstructive CAD who have identified CTOs.”

May 5, 2017 | TCTMD

“In a move that many hope will increase the dismally low numbers of patients undergoing primary angioplasty in India, lawmakers have declared that coronary stents are “essential medicines.” Prices for both bare-metal and drug-eluting stents there have now been capped at roughly 25% of their previous cost.”

May 1, 2017 | Industry Press Releases

“Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute Onyx(TM) Drug-Eluting Stent (DES). The Resolute Onyx DES builds on the proven clinical performance and superior deliverability of the Resolute Integrity(TM) DES to further strengthen the gold standard safety and efficacy of DES technology…”

Apr 17, 2017 | DAIC Articles

“To bolster its technology and treatment capabilities for coronary and peripheral artery diseases across all of its locations, Cardiovascular Institute of the South (CIS) installed 20 new Aplio 300 Platinum CV ultrasound systems from Toshiba Medical. CIS also upgraded 20 existing ultrasounds to Toshiba Medical’s Aplio 300 Platinum platform to ensure staff were offering consistent […]

Mar 13, 2017 | CathLab.com Articles

By Benjamin A. Post, Esquire & Gabrielle P. Kelerchian, Law Clerk, Post & Post, LLC   In 2012, a Pennsylvania jury awarded a $6,000,000 verdict to a plaintiff in a wrongful death action in which the patient died as a result of internal bleeding after a cardiac catheterization.  In Burkhardt v. Cardiac Diagnostic Associates, the […]

Mar 7, 2017 | Industry Press Releases

BTG plc (LSE: BTG), the global specialist healthcare company, today announced U.S. Food and Drug Administration 510(k) clearance has been granted to the EKOS® Control Unit 4.0. The EKOS® system includes an ultrasonic device that uses acoustic pulses, powered by the new Control Unit 4.0, to quickly and safely dissolve blood clots and restore blood […]

Nov 30, 2016 | CathLab.com Articles

Do we Phase Shift or Not? By Jeff Davis RRT-NPS, RCIS Significant advances have been made in the diagnosis and treatment of aortic stenosis. Innovations in catheter based interventional aortic valve procedures including, Transcatheter Aortic Valve Replacement (TAVR), have improved the lives of many patients and their families. Treatment options, including TAVR, are based on a […]

Filter by Journal

X